Community-aquired pneumonia associated with coronavirus disease (COVID-19): determination of pathological process progression predictors by clinical and hemocoagulation parameters

T.O. Pertseva; K.O. Bielosludtseva; L.I.  Konopkina; M.A. Krykhtina; O.V.  Myronenko; L.A.  Botvinikova; O.F.  Moiseienko

doi:10.26641/2307-0404.2022.1.254318

Authors

T.O. Pertseva Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0003-3473-2288
K.O. Bielosludtseva Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0002-9770-9950
L.I. Konopkina Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0002-2238-6501
M.A. Krykhtina Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0003-4620-1580
O.V. Myronenko Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0003-3514-3338
L.A. Botvinikova Dnipro State Medical University, V. Vernadskyi str., 9, Dnipro, 49044, Ukraine https://orcid.org/0000-0002-2347-6701
O.F. Moiseienko MNI “City Clinical Hospital #6" of Dnipro City Council, Batumska str., 13, Dnipro, 49074, Ukraine https://orcid.org/0000-0002-7222-7955

DOI:

https://doi.org/10.26641/2307-0404.2022.1.254318

Keywords:

community-acquired pneumonia, viral pneumonia, coronavirus disease, COVID-19, diagnosis, predictors of progression, risk factors for burden, D-dimer, fibrinogen, coagulogram

Abstract

The search for clinical and laboratory markers of COVID-19-associated CAP progression is an urgent problem of today. The aim of our study was to determine the risk factors for the burden of the pathological process by establishing the diagnostic and prognostic significance of clinical and hemocoagulation parameters in the hospital stage of management of patients with CAP on the background of coronavirus disease (COVID-19). The study included 53 individuals of the main group. All patients were examined twice: on the first day of hospitalization (visit 1) and in the dynamics (7-10 days after hospitalization (visit 2)). In 30 (83.3%) patients of subgroup 1, despite adequate treatment, there was an increase in breathing rate and a decrease in saturation to severe (less than 92%) or critical (less than 85%) levels (in 28 and 2 cases respectively). In subgroup 2, the progression of respiratory failure to a critical level was observed in 5 of 12 (41.7%) patients. Conclusions: at the stage of hospitalization of patients with COVID-19-associated CAP the most sensitive clinical predictor of aggravation of the patient's condition is tachypnea of 20 or more; laboratory – the level of D-dimer 200 ng/ml, which increases the risk of progression of the pathological process by 16 times.

References

Feschenko YuI, Belosludtseva KO, Golubovska OA, Gumenyuk MI, et al. [Adapted evidence-based clinical guideline "Nosocomial pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antimicrobial therapy and prevention"]. Vidannya ofitsiine. Kyiv: Natsionalna akademiya medichnih nauk; 2019. p. 94. Ukrainian.

[Order of the Ministry of Health of Ukraine dated 06.04.2021 No. 638 “Amendments to the Standards of Medical Care“ Coronavirus Disease (COVID19)”, ap¬proved by the order of the Ministry of Health of Ukraine dated April 02, 2020 No. 762]. (2020). Ukrainian.

Feshhenko YІ, Dzyublik YO, Dzyublik OY [Nosocomial pneumonia associated with COVID-19: a look at treatment]. Ukrainskyi pulmonolohіchnyi zhurnal. 2020;2:5-12. Ukrainian. doi: https://doi.org/10.31215/2306-4927-2020-108-2-5-12

Pertseva TO, Bielosludseva KO, Kirieieva TV, Konopkina LI, Krykhtina MA et al. [Nosocomial pneu¬monia on the background of coronavirus disease (covid-19): principles of diagnosis and determination of risk factors for the burden of the pathological process]. Medicnі perspektivi, 2020;25(3):50-61. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2020.3.214807

Pertseva TO, Konopkіna LІ, Yakovlieva VH. [Condition of coagulation hemostasis in patients with chronic obstructive pulmonary disease with severe disease]. Halytskyi lіkarskyi vіsnyk. 2015;22(2):74-77. Ukrainian. Available from:

http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?I21DBN=LINK&P21DBN=UJRN&Z21ID=&S21REF=10&S21CNR=20&S21STN=1&S21FMT=ASP_meta&C21COM=S&2_S21P03=FILA=&2_S21STR=glv_2015_22_2_25

Fetisov VS. [STATISTICA statistical data analysis package]. Nizhyn: NDU im. M. Gogolya; 2018. p. 114. Ukrainian.

Tsai P, Wei-Yi L, Yi-Ying L, Yung-Hung L, Yi-Tsung L, Hsiao-Kang C, et al. Clinical manifestation and disease progression in COVID-19 infection. JCMA. 2021;84(1):3-8. doi: https://doi.org/10.1097/JCMA.0000000000000463

Coronavirus disease (COVID-19) Weekly Epidemiological Update of World Health Organization: [Internet]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200817-weekly-epi-update-1.pdf?sfvrsn=b6d49a76_4

Hill JB, Garcia D, Crowther M, Savage B, Peress S, Chang K, et al. Frequency of venous thromboembolism in 6513 patients with COVID-19:a retrospective study. Thrombosis and hemostasis. 2020;4(21):5373-7. doi: https://doi.org/10.1182/bloodadvances.2020003083

Krykhitna MA, Bielosludtseva KO, Botvinikova LA, Matykina NN. Lung vessels thrombosis in hos¬pitalized patients with community-acquired pneumonia: role of endothelial function, hemostasis, fibrinolysis and inflammation on different phases of treatment. Wiadomosci lekarskie, 2019;72:1463-5. doi: https://doi.org/10.36740/WLek201908108

MedCalc's Free statistical calculators. [Internet]. Availeble from: https://www.medcalc.org/calc/

Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19. CHEST Guideline and Expert Panel Report. 2020;158(3):1143-63. doi: https://doi.org/10.1016/j.chest.2020.05.559

Sanjeev P, Saroa R, Palta A. Overview of the coagulation system. Indian Journal of Anaesthesia. 2014;58(8):515-23.

doi: https://doi.org/10.4103/0019-5049.144643

Vahey GM, Marshall KE, McDonald E, Martin SW, Tate JE, Midgley CM, et al. Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease. Emerging Infectious Diseases. 2020;27(2):385-95 doi: https://dx.doi.org/10.3201/eid2702.203729

He X, Yao F, Chen J, Wang Y, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Scientific Reports. 2021;11(1):1830.

doi: https://doi.org/10.1038/s41598-021-81300-w